Intravenous immunoglobulins: a treatment for Alzheimer's disease?

Por Hack, C, Scheltens, P
Publicado em 2004

Is the whole brain periventricular?

Por Barkhof, F, Scheltens, P
Publicado em 2006

Grey hair and grey matter

Por van de Pol, L, Scheltens, P
Publicado em 2004

Do MCI criteria in drug trials accurately identify subjects with predementia Alzheimer's disease?

Por Visser, P, Scheltens, P, Verhey, F
Publicado em 2005

Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: a comparative study

Por Wahlund, L., Julin, P., Johansson, S., Scheltens, P.
Publicado em 2000

Use of laboratory and imaging investigations in dementia

Por van der Flier, W M, Scheltens, P
Publicado em 2005

Epidemiology and risk factors of dementia

Por van der Flier, W M, Scheltens, P
Publicado em 2005

Visual rating of hippocampal atrophy: correlation with volumetry.

Por Vermersch, P, Leys, D, Scheltens, P, Barkhof, F
Publicado em 1994

Alzheimer's disease—one clinical syndrome, two radiological expressions: a study on blood pressure

Por de Leeuw, F-E, Barkhof, F, Scheltens, P
Publicado em 2004

Progression of cerebral white matter lesions in Alzheimer's disease: a new window for therapy?

Por de Leeuw, F-E, Barkhof, F, Scheltens, P
Publicado em 2005

Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer's disease

Por Rombouts, S, Barkhof, F, van Meel, C S, Scheltens, P
Publicado em 2002

Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment

Por Visser, P, Verhey, F, Hofman, P, Scheltens, P, Jolles, J
Publicado em 2002

A case of progressive aphasia without dementia: "temporal" Pick's disease?

Por Scheltens, P, Hazenberg, G J, Lindeboom, J, Valk, J, Wolters, E C
Publicado em 1990

Neuropsychological correlates of a right unilateral lacunar thalamic infarction

Por Werf, Y, Weerts, J, Jolles, J, Witter, M, Lindeboom, J, Scheltens, P.
Publicado em 1999

Carotid sinus syndrome is common in dementia with Lewy bodies and correlates with deep white matter lesions

Por Kenny, R, Shaw, F, O'Brien, J, Scheltens, P, Kalaria, R, Ballard, C
Publicado em 2004

Increased cortical atrophy in patients with Alzheimer's disease and type 2 diabetes mellitus

Por Biessels, G J, De Leeuw, F‐E, Lindeboom, J, Barkhof, F, Scheltens, P
Publicado em 2006

(99mTc)-HM-PAO SPECT and dementia in Parkinson's disease.

Por Kuiper, M A, Weinstein, H C, Bergmans, P L, Scheltens, P, Wolters, E C
Publicado em 1992

Temporal lobe rating scale: application to Alzheimer's disease and frontotemporal dementia

Por Galton, C, Gomez-Anson, B, Antoun, N, Scheltens, P, Patterson, K, Graves, M, Sahakian, B, Hodges, J
Publicado em 2001

The seven minute screen: a neurocognitive screening test highly sensitive to various types of dementia

Por Meulen, E, Schmand, B, van Campen, J P, de Koning, S J, Ponds, R, Scheltens, P, Verhey, F
Publicado em 2004

[(123)]FP-CIT SPECT scans initially rated as normal became abnormal over time in patients with probable dementia with Lewy bodies

Por van der Zande, J. J., Booij, J., Scheltens, P., Raijmakers, P. G. H. M., Lemstra, A. W.
Publicado no Eur J Nucl Med Mol Imaging (2016)